Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen

G. C. Kudva*, M. Chandy, D. Dennison, A. Srivastava, V. Bhushan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Sixty-two adults with acute lymphoblastic leukaemia (ALL) were treated with a modified BFM regimen. Forty-two (70%) achieved complete remission (CR). Twenty-two percent of all evaluable patients and 32.4 percent of complete responders are in continuous complete remission (CCR) at a median follow-up of 41 months (range 24-81 months). Long-term survival was better in T- ALL (47.1%) when compared to precursor-B ALL (4.8%) (P < 0.04).

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalIndian Journal of Cancer
Volume31
Issue number1
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Cancer Research
  • Medicine(all)
  • Oncology

Fingerprint

Dive into the research topics of 'Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen'. Together they form a unique fingerprint.

Cite this